J Moeller

1.3k total citations
24 papers, 1.1k citations indexed

About

J Moeller is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, J Moeller has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in J Moeller's work include Mast cells and histamine (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). J Moeller is often cited by papers focused on Mast cells and histamine (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). J Moeller collaborates with scholars based in Germany, Belgium and Slovakia. J Moeller's co-authors include Lothar Hültner, Stefan Endres, Peter G. Dormer, Edgar Schmitt, Andreas Eigler, Jacques Van Snick, Catherine Uyttenhove, Erwin Rüde, M Schönharting and Axel Alléra and has published in prestigious journals such as The Journal of Immunology, Infection and Immunity and European Journal of Immunology.

In The Last Decade

J Moeller

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Moeller Germany 16 579 332 277 180 91 24 1.1k
JB Weinberg United States 14 372 0.6× 321 1.0× 342 1.2× 82 0.5× 58 0.6× 19 1.2k
Antonio Tugores Spain 18 361 0.6× 550 1.7× 131 0.5× 191 1.1× 120 1.3× 57 1.3k
Claire Leveillé Canada 15 405 0.7× 268 0.8× 326 1.2× 74 0.4× 99 1.1× 25 1.0k
Hiroshi Kanamori Japan 20 601 1.0× 555 1.7× 162 0.6× 138 0.8× 66 0.7× 44 1.6k
Homayon Banie United States 14 651 1.1× 283 0.9× 290 1.0× 110 0.6× 106 1.2× 17 1.1k
Barbara Balestrieri United States 20 411 0.7× 577 1.7× 272 1.0× 78 0.4× 81 0.9× 35 1.2k
Sophie E. Broughton Australia 15 483 0.8× 306 0.9× 176 0.6× 309 1.7× 44 0.5× 25 1.3k
Fumihiko Hato Japan 19 576 1.0× 454 1.4× 85 0.3× 217 1.2× 132 1.5× 56 1.3k
Sharon H. Jackson United States 16 847 1.5× 530 1.6× 137 0.5× 188 1.0× 48 0.5× 25 1.5k
Julie Tebo United States 20 605 1.0× 387 1.2× 88 0.3× 270 1.5× 91 1.0× 28 1.1k

Countries citing papers authored by J Moeller

Since Specialization
Citations

This map shows the geographic impact of J Moeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Moeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Moeller more than expected).

Fields of papers citing papers by J Moeller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Moeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Moeller. The network helps show where J Moeller may publish in the future.

Co-authorship network of co-authors of J Moeller

This figure shows the co-authorship network connecting the top 25 collaborators of J Moeller. A scholar is included among the top collaborators of J Moeller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Moeller. J Moeller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staß, Heino, Johannes Nagelschmitz, J Moeller, & Heinz Delesen. (2004). Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 42(1). 23–30. 10 indexed citations
2.
Strumberg, Dirk, D. Voliotis, J Moeller, et al.. (2002). Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 580–581. 92 indexed citations
3.
Hilger, Ralf A., David W. Hedley, J Moeller, et al.. (2002). ERK1/2 phosphorylation: a biomarker analysis within a phase I study with the new Raf kinase inhibitor BAY43-9006. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 567–568. 15 indexed citations
4.
Hültner, Lothar, Michael Stassen, Jean-Pierre Kremer, et al.. (2000). In Activated Mast Cells, IL-1 Up-Regulates the Production of Several Th2-Related Cytokines Including IL-9. The Journal of Immunology. 164(11). 5556–5563. 112 indexed citations
5.
Sinha, Bhanu, et al.. (1998). Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells. Research in Immunology. 149(2). 139–150. 27 indexed citations
6.
Eigler, Andreas, et al.. (1998). The hairy cell leukemia cell line Eskol spontaneously synthesizes tumor necrosis factor-α and nitric oxide. Leukemia Research. 22(6). 501–507. 6 indexed citations
7.
Siegmund, Britta, Andreas Eigler, J Moeller, et al.. (1997). Suppression of tumor necrosis factor-α production by interleukin-10 is enhanced by cAMP-elevating agents. European Journal of Pharmacology. 321(2). 231–239. 29 indexed citations
8.
Hartmann, Gunther, Anne Krug, Andreas Eigler, et al.. (1996). Specific Suppression of Human Tumor Necrosis Factor-α Synthesis by Antisense Oligodeoxynucleotides. Antisense and Nucleic Acid Drug Development. 6(4). 291–299. 33 indexed citations
9.
Hültner, Lothar, et al.. (1996). Kinetics of interleukin‐6 production after experimental infection of mice with Schistosoma mansoni. Immunology. 89(2). 256–261. 13 indexed citations
10.
11.
Greten, Tim F., Andreas Eigler, Bhanu Sinha, J Moeller, & Stefan Endres. (1995). The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxide. International Journal of Immunopharmacology. 17(7). 605–610. 29 indexed citations
12.
Eigler, Andreas, J Moeller, & Stefan Endres. (1995). Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7.. The Journal of Immunology. 154(8). 4048–4054. 94 indexed citations
13.
Sinha, Bhanu, et al.. (1995). Radioimmunoassays for cyclic AMP cross-react with phosphodiesterase inhibitors and buffer components. Journal of Pharmacological and Toxicological Methods. 34(1). 29–36. 1 indexed citations
14.
Moeller, J, et al.. (1993). Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.. PubMed. 78(4). 520–5. 126 indexed citations
15.
Hültner, Lothar, J Moeller, Catherine Uyttenhove, et al.. (1990). Mast cell growth‐enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). European Journal of Immunology. 20(6). 1413–1416. 240 indexed citations
16.
Hültner, Lothar & J Moeller. (1990). Mast cell growth-enhancing activity (MEA) stimulates interleukin 6 production in a mouse bone marrow-derived mast cell line and a malignant subline.. PubMed. 18(8). 873–7. 31 indexed citations
17.
Moeller, J, Lothar Hültner, Edgar Schmitt, & Peter G. Dormer. (1989). Partial purification of a mast cell growth-enhancing activity and its separation from IL-3 and IL-4.. The Journal of Immunology. 142(10). 3447–3451. 28 indexed citations
18.
Hültner, Lothar, et al.. (1989). Interleukin 3 Mediates Interleukin 6 Production in Murine Interleukin 3-Dependent Hemopoietic Cells. Growth Factors. 2(1). 43–51. 4 indexed citations
19.
Hültner, Lothar, et al.. (1989). Mouse bone marrow-derived IL-3-dependent mast cells and autonomous sublines produce IL-6.. PubMed. 67(3). 408–13. 56 indexed citations
20.
Moeller, J, et al.. (1986). Reproducible generation of autonomous malignant sublines from non-tumorogenic murine interleukin 3-dependent mast cell lines. Annals of Hematology. 53(6). 451–455. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JB Weinberg Breakdown of academic impact, for papers by Antonio Tugores Breakdown of academic impact, for papers by Claire Leveillé Breakdown of academic impact, for papers by Hiroshi Kanamori Breakdown of academic impact, for papers by Homayon Banie Breakdown of academic impact, for papers by Barbara Balestrieri Breakdown of academic impact, for papers by Sophie E. Broughton Breakdown of academic impact, for papers by Fumihiko Hato Breakdown of academic impact, for papers by Sharon H. Jackson Breakdown of academic impact, for papers by Julie Tebo
Rankless by CCL
2026